Compare moats
Up to three covered companies, band by band. Every call is a curated editorial judgment, never a disclosed figure — and every band carries its cited basis.
| Digital Realty Trust | Eli Lilly and Company | Eaton | |
|---|---|---|---|
| Moat rating | narrow The FY2025 10-K's own competitive record cuts both ways. Item 1 says a "high-quality, highly interconnected global portfolio such as ours could not be easily replicated today on a cost-competitive basis," yet Item 1A concedes that competitors have "significantly greater financial, marketing and other resources and more ready access to capital" and that as rivals keep developing space, "rental rates may be reduced or we may face delays in leasing." A durable advantage that its own filing says new supply can price against is bounded, not unassailable. | wide Eli Lilly's FY2025 10-K states "Intellectual property protection is critical" and that compound patents provide roughly 20-year market exclusivity ("patents in each relevant country last for a period of 20 years"), warning that loss of patent protection causes a "severe and rapid decline in revenues." Backed by an 83.0% gross margin (up from 81.3% in 2024) and a fast-growing, patent-protected incretin franchise (Mounjaro +99%, Zepbound +175% in 2025), the economic moat is wide and durable. Source: LLY FY2025 10-K. | wide The FY2025 10-K asserts a durable competitive position across essentially all of the revenue base: for Electrical Americas and Electrical Global it states 'Eaton has a strong competitive position in these segments and, with respect to many products, is considered among the market leaders'; it repeats that language verbatim for Aerospace ('industry-leading portfolio', 'considered among the market leaders'); and for Vehicle it states 'Eaton is considered among the market leaders in this segment.' That is a claimed leadership position in four of the five reported segments, on a base of $27.4 billion of 2025 revenue, ~97,000 employees and customers in 180 countries, from a company founded in 1911. The rating is tempered rather than lifted higher by the filing's own admissions - price is named among the principal methods of competition in the Electrical, Vehicle and eMobility segments, and the risk factors flag 'newly competitive market players' and that 'our positions may also be impacted by new entrants into our product or regional markets.' |
| Moat type | network effects Item 1 attributes the hard-to-replicate part of the portfolio to connectivity rather than to real estate: "the network density, interconnection infrastructure and connectivity-centric customers in certain of our data centers have led to the organic formation of densely connected data communities that are difficult for competitors to replicate." That community sits on over 232,000 cross connects in over 55 metros, so each network and cloud that lands makes the same building worth more to the next tenant. | intangibles ip Per the LLY FY2025 10-K, the pharma protection "anticipated to be of most relevance" is "patents claiming the active ingredient (the compound patent)," supplemented by regulatory data protection, FDA approvals, and brands — i.e., intangible assets. The 10-K notes that without such protection, products face intense generic and biosimilar price competition that erodes revenue quickly. | switching costs The filing's own description of how it competes points at designed-in and qualified positions rather than IP or pure scale. In Aerospace the principal methods of competition are listed as 'total cost of ownership, product and system performance, quality, design engineering capabilities, and timely delivery' - price is conspicuously absent, and 20% of segment sales go to three large aircraft OEMs, i.e. platform-level content that is qualified in and hard to displace mid-programme. In the Electrical segments 'customer service and support' sits alongside performance and technology as a method of competition, and 22% of sales go to six large customers. Intangibles_ip is explicitly ruled out as the primary source by the company itself: 'management believes that the loss or expiration of any single intellectual property right would not in and of itself have a material effect on Eaton's consolidated financial statements or its business segments.' Scale is real but secondary - the filing notes raw materials are bought 'from many suppliers' and 'under normal circumstances, the Company has no difficulty obtaining its raw materials,' which reads as supply resilience rather than a cost advantage claim. |
| Leadership | co leader Item 1 claims the title of "the largest global provider of cloud- and carrier-neutral data center, colocation and interconnection solutions," but the Competition section names Equinix and NTT as operators of properties "similar to ours in some of the same metropolitan areas," plus Global Switch and regional operators abroad — a shared top tier on the company's own telling, not a solitary one. | co leader Duopoly with Novo Nordisk: Novo's own FY2025 20-F names "Novo Nordisk and Eli Lilly [as] the most significant companies measured by market share" in the global diabetes and GLP-1 markets. Lilly is ascendant — the 20-F concedes Wegovy's years-long US anti-obesity prescription lead "was overtaken by a competing GLP-1 based product in the beginning of 2025" (Lilly's tirzepatide) — but Novo still cites Ozempic as "the leading product by sales," so co-leader is the honest band. Sources: Novo Nordisk FY2025 20-F; LLY FY2025 10-K. | co leader The filing's leadership language is plural and hedged, not exclusive: 'considered among the market leaders' for the Electrical segments (qualified further by 'with respect to many products'), 'among the market leaders' for Aerospace, and 'Eaton is considered among the market leaders' for Vehicle. Nowhere does the 10-K claim to be the single leader in any market, and it never names a competitor or cites a market-share figure. 'Among the market leaders' maps to co_leader, not clear_leader. |
| Pricing power | strong FY2025 renewals signed re-priced upward in every bucket — +27.0% on greater-than-1 MW space ($146 to $186 per square foot), +4.6% on 0-1 MW ($268 to $280) and +43.0% on other ($49 to $71) — and MD&A expects average aggregate rental rates on 2026 renewals to be positive against the rates currently paid for the same space "on a GAAP basis and on a cash basis." On costs, the filing says utilities expense "is our largest expense category" and that "the vast majority of the expense is passed directly through to our customers," which it credits with significantly mitigating exposure to power-cost increases rather than removing it. The cap: Item 1A warns competitor development could still force rates down. | moderate Mixed. The LLY 10-K shows an 83.0% gross margin (up 1.7pp), evidence of strong list-price power on exclusive branded drugs; but it repeatedly notes 2025 revenue growth was "partially offset by lower realized prices" for both Mounjaro and Zepbound, alongside heavy PBM/formulary rebate pressure and default anti-obesity coverage restrictions (e.g., US self-insured employers "must generally opt in" for obesity-drug coverage). Net pricing power is therefore moderate, not strong. | moderate The filing describes pass-through ability that is real but bounded. On input costs: 'While we strive to recoup these increased costs through our pricing, product modifications or other mediating responses, if we are unable to do so without compromising the competitive position of our products and services, our results could continue to be impacted by this trend.' On macro conditions: 'our responses to mitigate the impact of these conditions, such as potential price increases, could negatively impact our market share or relationships with distributors or customers.' On tariffs: 'potential price increases or other mitigating efforts could negatively impact market share or otherwise increase the risk of customer disputes.' Price is also listed as a principal method of competition in Electrical Americas, Electrical Global, Vehicle and eMobility - so raising price is described by the company as costing share. Aerospace is the exception, where price is not among the listed methods of competition. The filing states no gross-margin trend in Item 1 or Item 1A. |
| Summary | Digital Realty rents space, power and connectivity rather than compute: at 2025 year-end its portfolio held 310 data centers and roughly 57.6 million rentable square feet across more than 55 metros in over 30 countries, about 84.7% leased, serving more than 5,000 customers. Two different businesses sit inside that footprint. The greater-than-1 MW wholesale side is a capital-and-power race — 769 MW of projects underway with 64% pre-leased, and land that "could accommodate over 3,500 megawatts of additional data center capacity" — where the 10-K names Equinix, NTT, Global Switch and "various private operators" as rivals and warns that added supply can push rents down. The colocation and interconnection side is the defended half: over 232,000 cross connects and the "densely connected data communities" Item 1 says competitors cannot easily replicate, reinforced by contracts the filing describes as generally running 5-10+ years on large deployments and by improvements "installed at our customers' expense." FY2025 leasing supports that read — renewals signed re-priced +27.0% on greater-than-1 MW space and +4.6% on 0-1 MW — while customer concentration is the offsetting exposure, with the largest customer at roughly 11.7% of annualized recurring revenue. | Lilly's moat rests on patent-protected, FDA-approved branded medicines led by its tirzepatide incretin franchise: per the FY2025 10-K, Mounjaro ($22.97B) and Zepbound ($13.54B) together generated roughly 56% of 2025's $65.2B revenue (up 99% and 175% respectively), while compound patents confer ~20-year market exclusivity and support an 83.0% gross margin. Durable competition only emerges after patents and regulatory data protection lapse, at which point the 10-K warns generics and biosimilars drive a "severe and rapid decline in revenues." | Eaton describes itself in the FY2025 10-K as an 'intelligent power management company' making products for the data center, utility, industrial, commercial, machine building, residential, aerospace and mobility markets, capitalising on 'the megatrends of the electrification, digitalization, and the reindustrialization of and growth of megaprojects in North America.' Its defensibility rests on positions the filing says are already at or near the front of their markets - a 'strong competitive position' in both Electrical segments and Aerospace, competed on performance, technology, service and, in Aerospace, engineering and total cost of ownership rather than price - reinforced by acquisitions aimed at owning more of the electrical value chain into the data center (Fibrebond for 'modular solutions for multi-tenant and hyperscale data center customers,' Resilient Power Systems to accelerate 'commercialization of solid-state transformer technology,' and an agreed acquisition of Boyd Thermal adding 'critical liquid cooling technology, enabling the Company to serve hyperscale and colocation customers from the chip to the grid'). The counterweight, stated by the company, is customer concentration and a portfolio in flux: on January 26, 2026 Eaton announced its intention to spin off its Mobility business (the legacy Vehicle and eMobility segments) into an independent public company, and re-segmented accordingly in Q1 2026. |
| Chain position | Landlord to the AI stack — sells the space, power and interconnection that cloud, network and enterprise tenants run compute in (Oracle, IBM, Meta Platforms, AT&T, Comcast and Lumen are among the customers named in Item 1), with roughly 2.9 GW of total in-place IT capacity. | Upstream branded-drug originator. Per the FY2025 10-K, US distribution flows through three wholesalers (McKesson, Cencora, Cardinal Health), each accounting for over 10% of consolidated revenue, into consolidated PBMs/payers whose formularies and rebate demands constrain net price; Lilly is also expanding a direct-to-patient channel, LillyDirect. | Upstream electrical infrastructure into AI compute: Eaton supplies the power path from grid to rack, and the 10-K makes that link itself - data center is the first market it names, it cites 'momentum in the data center and utility end markets,' and its 2025-26 acquisitions target hyperscale/colocation modular buildings, solid-state transformers and liquid cooling 'from the chip to the grid.' Its exposure to AI is as a supplier to AI buildout, not as an AI technology vendor; the filing's only AI discussion of its own products is a risk factor about keeping pace with AI internally and about generative-AI compliance risk, which is incidental to the thesis. |
| Products (share / barrier) |
|
|
|
| Long-horizon vote | +0.17 at weight 0.20 · swarm neutral Editorial prior, not backtested. | +0.30 at weight 0.20 · swarm neutral Editorial prior, not backtested. | +0.30 at weight 0.20 · swarm neutral Editorial prior, not backtested. |